This is particularly evident in breast cancer, where MACROD2 and FHIT are deleted in 28% and 15% of breast cancer cell lines, respectively, but either not at all (FHIT) or in only one out of 255 primary tumors (MACROD2) (Table S5). This evidence concerns the gene FHIT and breast cancer.